Characterization of the child population with oncological pathology in a reference center in the city of Bogotá-Colombia, descriptive cohort (2015 – 2020).
Caracterización de la población infantil con patología oncológica en un centro de referencia de la ciudad de Bogotá-Colombia, cohorte descriptiva (2015-2020)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Show authors biography
Pediatric oncological pathology represents a challenge for health systems; its diagnosis, management and prognosis depend on multiple factors that define the possibility of having access to quality medical care. Colombia is one of the Latin American countries with the highest incidence and mortality rate. Objective: to describe the characteristics of the pediatric population with oncological pathology at Hospital Infantil Universitario de San José between 2015 and 2020. Methods: a descriptive cohort study was carried out; Information was collected from the databases of the Hemato-Oncology Service - HIUSJ. Statistical analysis was done using relative and absolute frequencies for qualitative variables, measures of central tendency and dispersion for quantitative variables, and contingency tables. Results: of the 167 patients analyzed, 56% were male and 90% belonged to the contributory regime. Regarding oncological pathologies, 52% correspond to hematolymphoid neoplasias, among which B precursor ALL was the most frequent (29%). This pathology presented the shortest time between hospital admission and confirmatory diagnosis (12 days RIQ 9-17) and treatment (6 days RIQ 4-10). Conclusions: the results obtained in this study allow us to characterize the population and identify indicators during the care of these pathologies, which could define the proper management and prognosis of patients, which is why it is essential to continue recording these pathologies.
Article visits 344 | PDF visits 292
- Ramirez Wurttemberger O. Information and Childhood Cancer. Colomb Med (Cali) [Internet]. 2016;47(2):74-5. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975125/
- International Agency for Research on Cancer. GLOBOCAN 2020: Cancer today. Lyon, France: IARC [Internet]. 2022. Acceso: 2023. Disponible en: http://globocan.iarc.fr/.
- Tovar C. JR, Gómez GA. Incidencia de cáncer infantil en una ciudad colombiana. Revista Ciencias de la Salud [Internet]. 2016;14:315-28. https://doi.org/10.12804/revsalud14.03.2016.01
- Bernal CJG. Comportamiento epidemiológico del cáncer en menores de 18 años, Colombia, 2021. Instituto Nacional de Salud [Internet]. 2022. p. 1-5. Disponible en: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2022_Boletin_epidemiologico_semana_5.pdf
- Franco EL, Duarte-Franco E, Rohan TE. Evidence-based policy recommendations on cancer screening and prevention. Cancer Detect Prev [Internet]. 2002;26:350–61. Disponible en: https://doi.org/10.1016/S0361-090X(02)00118-6.
- Mullen C, Barr R, Franco EL. Timeliness of diagnosis and treatment: the challenge of childhood cancers. British Journal of Cancer [Internet]. 2021;125:1612–1620: https://doi.org/10.1038/s41416-021-01533-4
- Lupo PJ, Spector LG. Cancer Progress and Priorities: Childhood Cancer. Cancer Epidemiol Biomarkers Prev [Internet]. 2020 Jun;29(6):1081-1094. Disponible en: https://doi.org/10.1158/1055-9965.EPI-19-0941
- Situación del cáncer en la población pediátrica atendida en el SGSSS de Colombia 2020. Cuenta de Alto Costo. Fondo Colombiano de Enfermedades de Alto Costo [Internet] 2020. Disponible en: https://cuentadealtocosto.org/wp-content/uploads/2022/01/libro%20cancer%20infantil%202020.pdf
- Steliarova‐Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer. Cancer [Internet]. 2005;103:1457–67. Disponible en: https://doi.org/10.1002/cncr.20910
- StataCorp. 2021. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC.
- Villalba C, Martínez P, Acero H. Caracterización clínico-epidemiológica de los pacientes pediátricos con leucemias agudas en la Clínica Universitaria Colombia. Serie de casos 2011-2014. Pediatr [Internet]. 2016;49(1):17–22. Disponible en: https://doi.org/10.1016/j.rcpe.2016.01.002.
- Pollock BH, Krischer JP, Vietti TJ. Interval between symptom onset and diagnosis of pediatric solid tumours. J Pediatr [Internet]. 1991;119:725–732. Disponible en: https://doi.org/10.1016/S0022-3476(05)80287-2
- Manual de atención integrada a las enfermedades prevalentes de la infancia (0-5 años). AIEPI. 1st ed. Organización Panamericana de la Salud, Oficina Regional de la Organización Panamericana de la Salud [Internet]. 2014. Disponible en: https://www3.paho.org/hq/dmdocuments/2008/AIEPI_Americas_final.pdf
- Goyal S, Roscoe J, Ryder WD, Gattamaneni HR, Eden TO. Symptom interval in young people with bone cancer. Eur J Cancer [Internet] 2004;40:2280-2286. Disponible en: https://doi.org/10.1016/j.ejca.2004.05.017
- Dang-Tan T, Franco EL. Diagnosis Delays in Childhood Cancer A Review, American Cancer Society [internet]. 2007:703-713. Disponible en: https://doi.org/10.1002/cncr.22849
- Fajardo-Gutiérrez A, Sandoval-Mex AM, Mejia-Arangure JM, et al. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. Med Pediatr Oncol [Internet]. 2002;39:25-31. Disponible en: https://doi.org/10.1002/mpo.10100
- Haimi M, Peretz Nahum M, Ben Arush MW. Delay in diagnosis of children with cancer: a retrospective study of 315 children. Pediatr Hematol Oncol [Internet] 2004;21:37-48. Disponible en: https://doi.org/10.1080/08880010490263579
- Dang-Tan T, Trottier H, Mery L, Morrison H, Barr R, Greenberg M, Franco EL. Delays in Diagnosis and Treatment Among Children and Adolescents With Cancer in Canada. Pediatr Blood Cancer [Internet]. 2008;51:468-474. Disponible en: https://doi.org/10.1002/pbc.21600
- Pesola F, Ferlay J, Sasieni P. Cancer incidence in English children, adolescents and young people: past trends and projections to 2030. British Journal of Cancer [internet]. 2017;117:1865-1873. Disponible en: https://doi.org/10.1038/bjc.2017.341
- Ministerio Salud y Protección Social e Instituto Nacional Cancerología. Plan Decenal Control del Cáncer en Colombia 2012-2021 [Internet]. 2012. Disponible en: https://www.minsalud.gov.co/Documents/Plan-Decenal-Cancer/PlanDecenal_ControlCancer_2012-2021.pdf
- Guzmán P, Córdoba MA, Godoy N, Castaño A, Karina R, et al. Childhood cancer in Latin America: from detection to palliative care and survivorship. Cancer Epidemiology [Internet]. 2021;71. Disponible en: https://doi.org/10.1016/j.canep.2020.101837
- Saha V, Love S, Eden T, Micallef-Eynaud P, MacKinlay G. Determinants of symptom interval in childhood cancer. Arch Dis Child [Internet]. 1993;68:771–774. Disponible en: https://doi.org/10.1136/adc.68.6.771
- Lethaby C, Picton S, Kinsey S, Phillips R, Laar M, Feltbower R. A systematic review of time to diagnosis in children and young adults with cancer. Arch Dis Child [Internet]. 2013;0:1–7. Disponible en: https://doi.org/10.1136/archdischild-2012-303034
- Flores LE, Williams DL, Bell BA, et al. Delay in the diagnosis of pediatric brain tumours. Am J Dis Child [Internet]. 1986;140:684–686. Disponible en: https://doi.org/10.1007/s00431-002-1088-4
- Klein-Geltink JE, Shaw AK, Morrison HI, et al. Use of paediatric versus adult oncology treatment centres by adolescents 15–19 years old: The Canadian Childhood Cancer Surveillance and Control Program. Eur J Cancer [Internet]. 2005;41:404–410. Disponible en: https://doi.org/10.1016/j.ejca.2004.10.023
- Verma N, Bhattacharya S. Time to Diagnosis and Treatment of Childhood Cancer. The Indian Journal of Pediatrics [Internet]. 2020. Disponible en: https://doi.org/10.1007/s12098-020-03217-y
- Cabrera E., Martínez C., Aponte N. & García J. Caracterización de pacientes pediátricos con meduloblastoma tratados en un centro de referencia en Bogotá en el periodo 2011 a 2018. Rev.Col.Hematol.Oncol [Internet]. 2022;9(1). Disponible en: https://doi.org/10.51643/22562915.392
- Tasa de sobrevida de niños con cáncer aumenta del 40 al 60%. Ministerio de Salud y Protección Social [Internet]. 2022. Disponible en: https://www.minsalud.gov.co/Paginas/Tasa-de-sobrevida-de-ninos-con-cancer-aumenta-del-40-al-61.aspx